Literature DB >> 30135206

The proto-oncogene Bcl3 induces immune checkpoint PD-L1 expression, mediating proliferation of ovarian cancer cells.

Yue Zou1, Mohammad M Uddin1, Sveta Padmanabhan1, Yan Zhu1, Pengli Bu1, Ales Vancura1, Ivana Vancurova2.   

Abstract

The proto-oncogene Bcl3 induces survival and proliferation in cancer cells; however, its function and regulation in ovarian cancer (OC) remain unknown. Here, we show that Bcl3 expression is increased in human OC tissues. Surprisingly, however, we found that in addition to promoting survival, proliferation, and migration of OC cells, Bcl3 promotes both constitutive and interferon-γ (IFN)-induced expression of the immune checkpoint molecule PD-L1. The Bcl3 expression in OC cells is further increased by IFN, resulting in increased PD-L1 transcription. The mechanism consists of an IFN-induced, Bcl3- and p300-dependent PD-L1 promoter occupancy by Lys-314/315 acetylated p65 NF-κB. Blocking PD-L1 by neutralizing antibody reduces proliferation of OC cells overexpressing Bcl3, suggesting that the pro-proliferative effect of Bcl3 in OC cells is partly mediated by PD-L1. Together, this work identifies PD-L1 as a novel target of Bcl3, and links Bcl3 to IFNγ signaling and PD-L1-mediated immune escape.
© 2018 Zou et al.

Entities:  

Keywords:  Bcl3; PD-L1; immunology; interferon; oncogene; ovarian cancer; transcription regulation

Mesh:

Substances:

Year:  2018        PMID: 30135206      PMCID: PMC6177577          DOI: 10.1074/jbc.RA118.004084

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition.

Authors:  S D Westerheide; M W Mayo; V Anest; J L Hanson; A S Baldwin
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

2.  Bortezomib induces nuclear translocation of IκBα resulting in gene-specific suppression of NF-κB--dependent transcription and induction of apoptosis in CTCL.

Authors:  Ashish Juvekar; Subrata Manna; Sitharam Ramaswami; Tzu-Pei Chang; Hai-Yen Vu; Chandra C Ghosh; Mahmut Y Celiker; Ivana Vancurova
Journal:  Mol Cancer Res       Date:  2011-01-11       Impact factor: 5.852

3.  Identification of a transcriptional unit adjacent to the breakpoint in the 14;19 translocation of chronic lymphocytic leukemia.

Authors:  T W McKeithan; H Ohno; M O Diaz
Journal:  Genes Chromosomes Cancer       Date:  1990-01       Impact factor: 5.006

4.  PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-125b.

Authors:  Shuang Luo; Jidong Wang; Ying Ma; Zhenwei Yao; Hongjuan Pan
Journal:  Biochem Biophys Res Commun       Date:  2015-05-02       Impact factor: 3.575

5.  The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.

Authors:  R Dechend; F Hirano; K Lehmann; V Heissmeyer; S Ansieau; F G Wulczyn; C Scheidereit; A Leutz
Journal:  Oncogene       Date:  1999-06-03       Impact factor: 9.867

6.  Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.

Authors:  Neali D Hendrix; Rong Wu; Rork Kuick; Donald R Schwartz; Eric R Fearon; Kathleen R Cho
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

7.  Bcl3 Phosphorylation by Akt, Erk2, and IKK Is Required for Its Transcriptional Activity.

Authors:  Vivien Ya-Fan Wang; Yidan Li; Daniel Kim; Xiangyang Zhong; Qian Du; Majid Ghassemian; Gourisankar Ghosh
Journal:  Mol Cell       Date:  2017-07-06       Impact factor: 17.970

8.  Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3.

Authors:  Momoko Nishikori; Hitoshi Ohno; Hironori Haga; Takashi Uchiyama
Journal:  Cancer Sci       Date:  2005-08       Impact factor: 6.716

9.  Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.

Authors:  Curtis A Clark; Harshita B Gupta; Gangadhara Sareddy; Srilakshmi Pandeswara; Shunhua Lao; Bin Yuan; Justin M Drerup; Alvaro Padron; José Conejo-Garcia; Kruthi Murthy; Yang Liu; Mary Jo Turk; Kathrin Thedieck; Vincent Hurez; Rong Li; Ratna Vadlamudi; Tyler J Curiel
Journal:  Cancer Res       Date:  2016-09-26       Impact factor: 12.701

10.  Bcl-3 regulates TGFβ signaling by stabilizing Smad3 during breast cancer pulmonary metastasis.

Authors:  Xi Chen; Xinwei Cao; Xiaohua Sun; Rong Lei; Pengfei Chen; Yongxu Zhao; Yuhang Jiang; Jie Yin; Ran Chen; Deji Ye; Qi Wang; Zhanjie Liu; Sanhong Liu; Chunyan Cheng; Jie Mao; Yingyong Hou; Mingliang Wang; Ulrich Siebenlist; Y Eugene Chin; Ying Wang; Liu Cao; Guohong Hu; Xiaoren Zhang
Journal:  Cell Death Dis       Date:  2016-12-01       Impact factor: 8.469

View more
  15 in total

1.  IFNγ induces JAK1/STAT1/p65 NFκB-dependent interleukin-8 expression in ovarian cancer cells, resulting in their increased migration.

Authors:  Sveta Padmanabhan; Bijaya Gaire; Yue Zou; Mohammad M Uddin; Daniel DeLeon; Ivana Vancurova
Journal:  Int J Biochem Cell Biol       Date:  2021-10-06       Impact factor: 5.085

2.  IFNγ-induced PD-L1 expression in ovarian cancer cells is regulated by JAK1, STAT1 and IRF1 signaling.

Authors:  Sveta Padmanabhan; Bijaya Gaire; Yue Zou; Mohammad M Uddin; Ivana Vancurova
Journal:  Cell Signal       Date:  2022-07-09       Impact factor: 4.850

Review 3.  The role of B-Cell Lymphoma-3 (BCL-3) in enabling the hallmarks of cancer: implications for the treatment of colorectal carcinogenesis.

Authors:  Danny N Legge; Adam C Chambers; Christopher T Parker; Penny Timms; Tracey J Collard; Ann C Williams
Journal:  Carcinogenesis       Date:  2020-05-14       Impact factor: 4.944

Review 4.  Different Shades of L1CAM in the Pathophysiology of Cancer Stem Cells.

Authors:  Marco Giordano; Ugo Cavallaro
Journal:  J Clin Med       Date:  2020-05-16       Impact factor: 4.241

5.  Inhibitory Effect of Hesperidin on the Expression of Programmed Death Ligand (PD-L1) in Breast Cancer.

Authors:  Prachya Kongtawelert; Benjawan Wudtiwai; Thuzar Hla Shwe; Peraphan Pothacharoen; Thanyaluck Phitak
Journal:  Molecules       Date:  2020-01-08       Impact factor: 4.411

6.  Salmonella Breaks Tumor Immune Tolerance by Downregulating Tumor Programmed Death-Ligand 1 Expression.

Authors:  Man-Chin Chen; Christian Ronquillo Pangilinan; Che-Hsin Lee
Journal:  Cancers (Basel)       Date:  2019-12-24       Impact factor: 6.639

Review 7.  Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer.

Authors:  Samia S Messeha; Najla O Zarmouh; Karam F A Soliman
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

Review 8.  NF-κB and Its Role in Checkpoint Control.

Authors:  Annika C Betzler; Marie-Nicole Theodoraki; Patrick J Schuler; Johannes Döscher; Simon Laban; Thomas K Hoffmann; Cornelia Brunner
Journal:  Int J Mol Sci       Date:  2020-05-31       Impact factor: 5.923

9.  The Influence of Bcl-3 Expression on Cell Migration and Chemosensitivity of Gastric Cancer Cells via Regulating Hypoxia-Induced Protective Autophagy.

Authors:  Lin Hu; Zhigang Bai; Xuemei Ma; Nan Bai; Zhongtao Zhang
Journal:  J Gastric Cancer       Date:  2020-03-20       Impact factor: 3.720

10.  Knockdown of long non-coding RNA LINC00176 suppresses ovarian cancer progression by BCL3-mediated down-regulation of ceruloplasmin.

Authors:  Lan Dai; Jixiang Niu; Yanli Feng
Journal:  J Cell Mol Med       Date:  2019-10-30       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.